Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
Coronavirus,Coronavirus Vaccine,Pfizer,Children
From the Center
AllSides Media Bias Rating: Center
The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
September Jobs Report Adds 29,000 Jobs, Less Than Expected
October 2nd, 2026
Headline Roundup
Trump Admin Begins Sending $500 ACA Refund Checks
October 1st, 2026
.png.webp)
The Insight: Americans’ trust in the news media is rising. What’s behind the shift?
AllSides Staff
October 2nd, 2026
